Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
ARTHRITIS CARE & RESEARCH
Volume 66, Issue 7, Pages 1016-1026
Publisher
Wiley
Online
2013-12-11
DOI
10.1002/acr.22246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
- (2012) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis
- (2012) Ana C. Ribeiro et al. ARTHRITIS CARE & RESEARCH
- Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice
- (2011) A. C. M. Ribeiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
- (2011) Meliha Crnkic Kapetanovic et al. ARTHRITIS AND RHEUMATISM
- Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
- (2011) Cem Gabay et al. ARTHRITIS AND RHEUMATISM
- Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs
- (2011) Meliha Crnkic Kapetanovic et al. CLINICAL RHEUMATOLOGY
- Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study
- (2011) S. Adler et al. RHEUMATOLOGY
- The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
- (2011) U. Arad et al. VACCINE
- Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
- (2011) Ori Elkayam et al. ARTHRITIS CARE & RESEARCH
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2010) S. van Assen et al. ANNALS OF THE RHEUMATIC DISEASES
- Vaccinations in patients with immune-mediated inflammatory diseases
- (2010) J.-F. Rahier et al. RHEUMATOLOGY
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
- (2009) Ori Elkayam et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory
- (2008) Andrés de Roux et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started